http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Applied DNA Sciences (APDN) to Reports Q4 Results on Thursday, December 9, 2021
-
Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021
-
Pre-Open Stock Movers 11/29: (KRYS) (ADGI) (TWTR) Higher; (MRK) (UPS) Lower (more...)
-
Applied DNA Sciences (APDN) Unveils Strategy to Address Omicron SARS-CoV-2 Variant, Announces Linea 2.0 COVID-19 Assay Kit
-
Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit
-
Applied DNA Sciences' (APDN) LineaRx Receives Repeat Orders for LinearDNA
-
Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer
-
Applied DNA Sciences (APDN) Announces Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
-
Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
-
Applied DNA Sciences (APDN) and CLEARED4 Announce Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing
-
Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing
-
Applied DNA Sciences (APDN) Applies for Emergency Use Authorization to FDA for Line SARS-CoV-2 Mutation Panel
-
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
-
Applied DNA Sciences (APDN) Announces Collaboration with Ganesha Ecosphere to Deploy CertainT
-
Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain
-
Applied DNA Sciences (APDN) Announces Sarah Lawrence College Implements safeCircle COVID-19 Testing Program
-
Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College
-
Applied DNA Sciences (APDN) Announces $1.6M Purchase Order to Tag Textile Fibers
-
Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers
-
Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
-
Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
-
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
-
Applied DNA Sciences (APDN) Receives Suffolk County Community College COVID-19 Testing Contract
-
Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
-
Applied DNA Announces Third Quarter Fiscal 2021
-
Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
-
Applied DNA Sciences (APDN) Awarded The City University of New York (CUNY) COVID-19 Testing Contract
-
Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
-
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
-
Applied DNA Sciences (APDN) Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
-
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial La
-
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
-
Applied DNA Sciences (APDN) Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
-
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
-
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
-
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
-
Applied DNA Sciences (APDN) Announces FDA Grants EUA to LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
-
FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
-
Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
-
Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021
-
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
-
Applied DNA Sciences (APDN) Signs New Contract with U.S. Defense Logistics Agency
-
Applied DNA Signs New Contract with U.S. Defense Logistics Agency
-
Applied DNA Sciences (APDN) Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
-
Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
-
Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update
-
Applied DNA Sciences (APDN), Evvivax announce positive preliminary Phase I clinical trial results for a LinearDNA COVID-19 vaccine candidate
-
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
-
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
-
Applied DNA Sciences (APDN) and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program

